Lifestyle Choices and Prostate Cancer
This fact sheet reviews a large epidemiologic study about lifestyle choices, such as diet and exercise, and risk of developing prostate cancer.
Prostate Cancer
PROSTATE CANCER ADVISOR
FEATURED CONTENT
-
-
The Questionable Practice That Permeates Oncology Clinical Trials
Most oncology phase 1 trials use a simplistic, outdated dose-finding technique, and experts agree that change is needed. -
Integrative Oncology: Using Evidence-Informed Medicine to Improve Patient Outcomes and Quality of Life
Lifestyle-based integrative treatment approaches — deemed scientifically sound by the field’s proponents — merge conventional and complementary treatments. -
Patient-Reported Outcomes That May Affect Treatment Decisions in Prostate Cancer
Validated PROMs can assist in providing high-quality care and improve a patient’s overall experience. -
The Unexpected Costs of Cancer Treatment: Out-of-Network Billing
The cancer field is not immune to the challenges of out-of-network and surprise billing.
Current Research Into Pain Assessment
Immunotherapy for Prostate Cancer
Targeted Agents
Targeted Agents (cont.)
Radium-223
Chemotherapy
Immunotherapy
Treatment Sequencing
Androgen Deprivation Therapy
Duration of ADT
Docetaxel in Combination With ADT
HSD3B1 Allele Inheritance Linked With ADT Resistance
ADT and Radiation
Predictions for the Future
PROSTATE CANCER NEWS
Functional Outcomes Similar Across Localized Prostate Cancer Treatments
Overall Survival in mCRPC Cases Linked to Number of Radium-223 Doses
Radium-223 Plus Sipuleucel-T Found to Slow mCRPC Progression
Earlier Cabazitaxel Use in mCRPC Possibly Beneficial
Intermittent Enzalutamide Dosing for mCRPC Probed
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
